欢迎访问《现代生物医学进展》编辑部！

摘要目的：探讨实施临床路径后对2 型糖尿病患者的影响。方法：选择某三甲医院2011 年前未实施临床路径和2011 年实施临床路径后诊断为2 型糖尿病的患者，观察比较实施临床路径前后2 型糖尿病患者的平均住院日、再住院率、住院费用、药费、耗材费、检查费以及2 型糖尿病治愈、好转、死亡等效果等指标有无差异。结果：实施临床路径前后2 型糖尿病患者的平均住院日、再住院率、住院费用、药费、耗材费、检查费以及2 型糖尿病治愈、好转、死亡等效果相比较有明显差异(P<0.01)。结论：2 型糖尿病人治疗中实施临床路径可显著缩短平均住院日，降低平均住院费、药费、耗材费及检查费用, 再住院率明显降低，实施临床路径后2 型糖尿病治愈、好转、死亡等效果比实施临床路径前明显改善。临床路径的开展和应用, 使患者在最合适的时机得到最合理的检测、诊断和治疗，大大优化医疗资源，改善治疗结局，具有临床应用价值，值得临床推广和应用。

英文摘要:

ABSTRACT Objective:To investigate the effect of the clinical pathway on patients with type 2 diabetes mellitus.Methods: The patients with type 2 diabetes patients without implemented the clinical pathway before and performed the clinical pathway in 2011 were chosen, then the difference in average day in hospital, hospital admission rates again, hospital cost, expenses for medicine, material fee, examination fee and type 2 diabetes cure rate, improvement, death were detectedq. Results:After perform the clinical pathway on patients with type 2 diabetes, the average day in hospital, hospital admission rates again, hospital cost, expenses for medicine, material fee, examination fee and type 2 diabetes cure rate, improvement, death effects had obvious difference (P<0.01). Conclusion:Perform clinical pathway on patients with type 2 diabetes can significantly shorten the average day in hospital, reduce the average hospitalization expenses, expenses for medicine, material fee and checking expenses, and the hospitalization rate was reduced significantly. The development and application of clinical pathway can optimize medical resources, improve the treatment outcome, with a great clinical application value.

View Full Text View/Add Comment Download reader